Agency Forms Undergoing Paperwork Reduction Act Review, 18503-18504 [2010-8259]
Download as PDF
<![CDATA[
18503
Federal Register / Vol. 75, No. 69 / Monday, April 12, 2010 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
HIV Testing Form ..............................
Health jurisdictions (HV Testingscan).
Health jurisdictions (HIV Testing
non-scan).
Health jurisdictions (Training) ..........
Community-Based Organizations ....
Community-Based
Organizations
(HIV Testing).
Community-Based
Organizations
(Training).
...........................................................
NHM&E Data Variables and Values
NHM&E Data Variables and Values
NHM&E Data Variables and Values
HIV Testing Form ..............................
NHM&E Data Variables and Values
Total ...........................................
Number of
responses
per
respondent
Number of
respondents
Form name
4
616
73,920
35
4
439
61,460
65
300
100
4
4
4
10
84
30
2,600
100,800
12,000
300
4
10
12,000
........................
........................
........................
301,260
Community Health, National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
[FR Doc. 2010–8261 Filed 4–9–10; 8:45 am]
Background and Brief Description
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day 10–0650]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Prevention Research Centers Program
National Evaluation Reporting System
(OMB No. 0920–0650 exp. 8/31/2010)—
Revision—Division of Adult and
Total burden
(in hours)
30
Dated: April 5, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
BILLING CODE 4163–18–P
Average
burden
per response
(in hours)
The Prevention Research Centers
(PRC) Program was established by
Congress through the Health Promotion
and Disease Prevention Amendments of
1984. PRCs conduct outcomes-oriented
health promotion and disease
prevention research on a broad range of
topics using a multi-disciplinary and
community-based approach. CDC
manages the PRC program and currently
provides funding to PRC grantees that
are housed within schools of public
health, medicine, or osteopathy. Awards
are made for five years and renewed
through a competitive application
process.
CDC is currently approved to collect
progress and performance information
about PRCs through the PRC
Information System (IS), a Web-based
application (OMB no. 0920–0650, exp.
8/31/2010). The performance
information is used to track each PRC’s
progress toward, and achievement of,
the objectives established by the PRC
Program and the PRC’s individual work
plan, including indicators related to
research projects, products resulting
from those projects, trainings related to
those projects, and partnerships.
Information has been collected through
the PRC IS twice per year.
In the next approval period,
information collection will be
restructured around a revised set of
performance indicators and revised
information collection methodology.
The frequency of reporting will be
reduced to once per year, however,
reporting will be divided into two parts.
The first information collection will be
conducted electronically utilizing
Survey Monkey, a more user-friendly
Web-based survey system. This
information collection will include the
following: (1) PRC involvement with
State and local health departments and
other government agencies, (2) number
and characteristics of research projects,
(3) number of training programs
delivered, (4) number of people trained,
and (5) number of students trained. The
second information collection will
consist of a telephone interview with a
key contact for each PRC grantee. The
data will include the: (1) Number of
new people hired, (2) number of
contracts entered into and supported by
PRC core funds, and (3) number of
effective interventions. Although the
number of respondents will increase
from 33 to 37 PRCs, the proposed
changes will result in a net decrease in
the total estimated annualized burden to
respondents, due primarily to a decrease
in the burden per respondent.
OMB approval is being requested for
a three-year period with a start date of
June 1, 2010. There are no costs to
respondents other than their time. The
total estimated burden hours are 259.
sroberts on DSKD5P82C1PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
PRC Program ..................................................
Survey ............................................................
VerDate Nov<24>2008
17:58 Apr 09, 2010
Jkt 220001
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
E:\FR\FM\12APN1.SGM
37
12APN1
Number of responses per
respondent
1
Average
burden per
response
(in hours)
6
18504
Federal Register / Vol. 75, No. 69 / Monday, April 12, 2010 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Number of
respondents
Form name
Telephone Interview .......................................
Dated: April 6, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–8259 Filed 4–9–10; 8:45 am]
[Docket No. FDA–2010–D–0166]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices: Notice of Charter Renewal
sroberts on DSKD5P82C1PROD with NOTICES
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Advisory Committee on Immunization
Practices, Centers for Disease Control
and Prevention, Department of Health
and Human Services, has been renewed
for a 2-year period through April 1,
2012.
For information, contact Larry
Pickering, M.D., Executive Secretary,
Advisory Committee on Immunization
Practices, Centers for Disease Control
and Prevention, Department of Health
and Human Services, 1600 Clifton Road,
NE., Mailstop E05, Atlanta, Georgia
30333, telephone 404/639–8767 or fax
404/639–8626.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: April 6, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–8254 Filed 4–9–10; 8:45 am]
BILLING CODE 4163–18–P
VerDate Nov<24>2008
17:58 Apr 09, 2010
Jkt 220001
Food and Drug Administration
International Cooperation on
Harmonisation of Technical
Requirements for Registration of
Veterinary Medicinal Products; Draft
Guidance for Industry on Studies to
Evaluate the Metabolism and Residue
Kinetics of Veterinary Drugs in FoodProducing Animals: Marker Residue
Depletion Studies to Establish Product
Withdrawal Periods (VICH GL48);
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of a draft guidance for
industry (#207) entitled ‘‘Draft Guidance
for Industry on Studies to Evaluate the
Metabolism and Residue Kinetics of
Veterinary Drugs in Food-Producing
Animals: Marker Residue Depletion
Studies to Establish Product Withdrawal
Periods,’’ (VICH GL48). This draft
guidance has been developed for
veterinary use by the International
Cooperation on Harmonisation of
Technical Requirements for Registration
of Veterinary Medicinal Products
(VICH). This draft VICH guidance
document is intended to provide study
design recommendations which will
facilitate the universal acceptance of the
generated residue depletion data to
fulfill this recommendation.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
written or electronic comments on the
draft guidance by May 12, 2010.
ADDRESSES: Submit written requests for
single copies of the draft guidance to the
Communications Staff (HFV–12), Center
for Veterinary Medicine, Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855. Send one selfaddressed adhesive label to assist that
office in processing your requests.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
37
Number of responses per
respondent
1
Average
burden per
response
(in hours)
1
Submit written comments on the draft
guidance to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.regulations.gov. See the
SUPPLEMENTARY INFORMATION section for
electronic access to the draft guidance
document.
FOR FURTHER INFORMATION CONTACT: Julia
Oriani, Center for Veterinary Medicine
(HFV–151), Food and Drug
Administration, 7500 Standish Pl.,
Rockville, MD 20855, 240–276–8204, email: julia.oriani@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
a draft guidance for industry (#207)
entitled ‘‘Draft Guidance for Industry on
Studies to Evaluate the Metabolism and
Residue Kinetics of Veterinary Drugs in
Food-Producing Animals: Marker
Residue Depletion Studies to Establish
Product Withdrawal Periods,’’ (VICH
GL48). In recent years, many important
initiatives have been undertaken by
regulatory authorities and industry
associations to promote the
international harmonization of
regulatory requirements. FDA has
participated in efforts to enhance
harmonization and has expressed its
commitment to seek scientifically based
harmonized technical procedures for the
development of pharmaceutical
products. One of the goals of
harmonization is to identify and then
reduce differences in technical
requirements for drug development
among regulatory agencies in different
countries.
FDA has actively participated in the
International Conference on
Harmonisation of Technical
Requirements for Approval of
Pharmaceuticals for Human Use for
several years to develop harmonized
technical requirements for the approval
of human pharmaceutical and biological
products among the European Union
(EU), Japan, and the United States. The
VICH is a parallel initiative for
veterinary medicinal products. The
VICH is concerned with developing
harmonized technical requirements for
the approval of veterinary medicinal
E:\FR\FM\12APN1.SGM
12APN1
]]>Agencies
[Federal Register Volume 75, Number 69 (Monday, April 12, 2010)]
[Notices]
[Pages 18503-18504]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-8259]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day 10-0650]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-5806.
Written comments should be received within 30 days of this notice.
Proposed Project
Prevention Research Centers Program National Evaluation Reporting
System (OMB No. 0920-0650 exp. 8/31/2010)--Revision--Division of Adult
and Community Health, National Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Prevention Research Centers (PRC) Program was established by
Congress through the Health Promotion and Disease Prevention Amendments
of 1984. PRCs conduct outcomes-oriented health promotion and disease
prevention research on a broad range of topics using a multi-
disciplinary and community-based approach. CDC manages the PRC program
and currently provides funding to PRC grantees that are housed within
schools of public health, medicine, or osteopathy. Awards are made for
five years and renewed through a competitive application process.
CDC is currently approved to collect progress and performance
information about PRCs through the PRC Information System (IS), a Web-
based application (OMB no. 0920-0650, exp. 8/31/2010). The performance
information is used to track each PRC's progress toward, and
achievement of, the objectives established by the PRC Program and the
PRC's individual work plan, including indicators related to research
projects, products resulting from those projects, trainings related to
those projects, and partnerships. Information has been collected
through the PRC IS twice per year.
In the next approval period, information collection will be
restructured around a revised set of performance indicators and revised
information collection methodology. The frequency of reporting will be
reduced to once per year, however, reporting will be divided into two
parts. The first information collection will be conducted
electronically utilizing Survey Monkey, a more user-friendly Web-based
survey system. This information collection will include the following:
(1) PRC involvement with State and local health departments and other
government agencies, (2) number and characteristics of research
projects, (3) number of training programs delivered, (4) number of
people trained, and (5) number of students trained. The second
information collection will consist of a telephone interview with a key
contact for each PRC grantee. The data will include the: (1) Number of
new people hired, (2) number of contracts entered into and supported by
PRC core funds, and (3) number of effective interventions. Although the
number of respondents will increase from 33 to 37 PRCs, the proposed
changes will result in a net decrease in the total estimated annualized
burden to respondents, due primarily to a decrease in the burden per
respondent.
OMB approval is being requested for a three-year period with a
start date of June 1, 2010. There are no costs to respondents other
than their time. The total estimated burden hours are 259.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
PRC Program........................... Survey.................. 37 1 6
-------------------------------------------------------------------------
[[Page 18504]]
Telephone Interview..... 37 1 1
----------------------------------------------------------------------------------------------------------------
Dated: April 6, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2010-8259 Filed 4-9-10; 8:45 am]
BILLING CODE 4163-18-P
